共 209 条
- [1] Basarslan F(2012)Protective effects of thymoquinone on vancomycin-induced nephrotoxicity in rats Hum Exp Toxicol 31 726-733
- [2] Yilmaz N(2015)Protective effects of cilastatin against vancomycin-induced nephrotoxicity Biomed Res Int 2015 12-2609
- [3] Ates S(2016)Optimizing the clinical use of vancomycin Antimicrob Agents Chemother 60 2601-24
- [4] Ozgur T(2010)Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of health-system pharmacists, the infectious diseases society of America, and the society of infectious diseases pharmacists Clin Biochem Rev 31 21-1279
- [5] Tutanc M(2009)Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American society of health-system pharmacists, the infectious diseases society of America, and the society of infectious diseases pharmacists Pharmacother 29 1275-744
- [6] Motor VK(2013)Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter Antimicrob Agents Chemother 57 734-1185
- [7] Arica V(2007)Novel evidence suggesting an anti-oxidant property for erythropoietin on vancomycin-induced nephrotoxicity in a rat model Clin Exp Pharmacol Physiol 34 1181-553
- [8] Yilmaz C(2014)Vancomycin nephrotoxicity: a review J Pharm Pract 27 545-687
- [9] Inci M(1990)Nephrotoxicity of vancomycin, alone and with an aminoglycoside J Antimicrob Chemother 25 679-1873
- [10] Buyukbas S(2012)Mitochondrial superoxide production contributes to vancomycin-induced renal tubular cell apoptosis Free Radic Biol Med 52 1865-383